Antrodia cinnamomea for Fatigue
Verdict: Insufficient Evidence
Across 2 PubMed studies, the evidence for Antrodia cinnamomea in Fatigue grades Tier U — unverified / insufficient. Research is still too limited to draw a firm conclusion.
U ⚫ U Unverified Insufficient Evidence
Why this grade7-layer evidence engine
⚖️
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditableRaw score 0.44
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Insufficient Evidence
Confidence
42%
Conflicting evidence
Evidence level
E6
Multiple smaller RCTs (n<500)
▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.44
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — | C→U 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
PubMed studies (2)L2 · primary research & systematic reviews
Triterpenoid-Rich Extract from Antrodia camphorata Improves Physical Fatigue and Exercise Performance in Mice
Finding: Dose-dependent increase in swim time and grip strength; 200 mg/kg significantly reduced lactate and ammonia and increased glycogen (p<0.0001).
View on PubMed Antifatigue Effects of Antrodia cinnamomea Cultured Mycelium via Modulation of Oxidative Stress Signaling in a Mouse Model
Finding: 0.9 g/kg prolonged exhaustive running ~35% (53.9 vs 39.8 min, p<0.01); swim endurance +66% at 0.3-0.9 g/kg.
View on PubMed Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …
L4a US FDA
Cautious
cancer fighting properties source↗
L4b EU EFSA
Cautious
The Panel concludes that the NF, freeze-dried mycelia of Antrodia camphorata, is safe at the proposed use level for individuals aged 14 years and above. ... maximum dose of 990 mg per day ... in food supplements as defined in Directive 2002/46/EC ... for the general population. source↗